Low-dose imatinib in the treatment of severe systemic sclerosis: a case series of six Chinese patients and literature review.
about
Pharmacology and rationale for imatinib in the treatment of sclerodermaLow-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.Ethnic difference may contribute to the efficacy of low-dose imatinib mesylate in systemic sclerosis.
P2860
Low-dose imatinib in the treatment of severe systemic sclerosis: a case series of six Chinese patients and literature review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Low-dose imatinib in the treat ...... atients and literature review.
@en
type
label
Low-dose imatinib in the treat ...... atients and literature review.
@en
prefLabel
Low-dose imatinib in the treat ...... atients and literature review.
@en
P2093
P2860
P1476
Low-dose imatinib in the treat ...... atients and literature review.
@en
P2093
He-jian Zou
Xiao-xiang Chen
Yue-ying Gu
P2860
P304
P356
10.1007/S10067-012-2032-2
P577
2012-08-09T00:00:00Z